Achilles Therapeutics plc (ACHL)
NASDAQ: ACHL · Real-Time Price · USD
1.045
+0.005 (0.48%)
At close: Nov 7, 2024, 4:00 PM
1.031
-0.014 (-1.34%)
After-hours: Nov 7, 2024, 5:36 PM EST
Achilles Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 95.11 | 131.54 | 173.34 | 266.32 | 177.85 | 97.59 | Upgrade
|
| Short-Term Investments | - | - | - | - | - | 0.27 | Upgrade
|
| Cash & Short-Term Investments | 95.11 | 131.54 | 173.34 | 266.32 | 177.85 | 97.86 | Upgrade
|
| Cash Growth | -33.82% | -24.11% | -34.91% | 49.74% | 81.74% | 816.03% | Upgrade
|
| Other Receivables | 18.35 | 10.35 | 16 | 11.17 | 7.34 | 4.49 | Upgrade
|
| Receivables | 18.35 | 10.35 | 16 | 11.17 | 7.34 | 4.49 | Upgrade
|
| Prepaid Expenses | 2.23 | 1.76 | 4.62 | 5.13 | 0.77 | 0.24 | Upgrade
|
| Other Current Assets | 2.13 | 1.98 | 2.62 | 2.12 | 1.84 | 0.48 | Upgrade
|
| Total Current Assets | 117.82 | 145.63 | 196.58 | 284.75 | 187.8 | 103.06 | Upgrade
|
| Property, Plant & Equipment | 11.12 | 13.54 | 20.48 | 28.79 | 28.11 | 2.11 | Upgrade
|
| Long-Term Deferred Tax Assets | 0.04 | 0.04 | 0.25 | 0.03 | 0 | - | Upgrade
|
| Other Long-Term Assets | 2.21 | 2.24 | 3.05 | 3.54 | 3.01 | 0.03 | Upgrade
|
| Total Assets | 131.19 | 161.46 | 220.36 | 317.11 | 218.92 | 105.21 | Upgrade
|
| Accounts Payable | 2.87 | 5.63 | 5.19 | 3.72 | 6.31 | 0.9 | Upgrade
|
| Accrued Expenses | 6.12 | 6.86 | 6.87 | 8.93 | 5.79 | 1.79 | Upgrade
|
| Current Portion of Leases | 4.21 | 3.54 | 4.19 | 4.48 | 3.71 | 0.49 | Upgrade
|
| Current Income Taxes Payable | - | - | 0.33 | - | 0.01 | - | Upgrade
|
| Other Current Liabilities | 1.11 | 0.97 | 1.43 | 1.98 | 0.81 | 0.68 | Upgrade
|
| Total Current Liabilities | 14.3 | 17 | 17.99 | 19.11 | 16.62 | 3.86 | Upgrade
|
| Long-Term Leases | 0.26 | 1.08 | 4.39 | 7.78 | 12.27 | - | Upgrade
|
| Other Long-Term Liabilities | 1.16 | 1.02 | 0.93 | 0.69 | 0.65 | - | Upgrade
|
| Total Liabilities | 15.71 | 19.09 | 23.31 | 27.58 | 29.55 | 3.86 | Upgrade
|
| Common Stock | 0.05 | 0.05 | 0.05 | 0.05 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 417.91 | 415.21 | 408.84 | 401.82 | 234.92 | 117.96 | Upgrade
|
| Retained Earnings | -288.61 | -259.95 | -190.29 | -119.11 | -58.01 | -24.81 | Upgrade
|
| Comprehensive Income & Other | -13.89 | -12.94 | -21.57 | 6.76 | 12.32 | 8.11 | Upgrade
|
| Total Common Equity | 115.48 | 142.37 | 197.04 | 289.53 | 189.24 | 101.27 | Upgrade
|
| Shareholders' Equity | 115.48 | 142.37 | 197.04 | 289.53 | 189.37 | 101.35 | Upgrade
|
| Total Liabilities & Equity | 131.19 | 161.46 | 220.36 | 317.11 | 218.92 | 105.21 | Upgrade
|
| Total Debt | 4.46 | 4.62 | 8.58 | 12.26 | 15.98 | 0.49 | Upgrade
|
| Net Cash (Debt) | 90.65 | 126.92 | 164.76 | 254.06 | 161.87 | 97.37 | Upgrade
|
| Net Cash Growth | -32.89% | -22.97% | -35.15% | 56.96% | 66.23% | 811.47% | Upgrade
|
| Net Cash Per Share | 2.25 | 3.18 | 4.21 | 8.87 | 151.81 | 151.63 | Upgrade
|
| Filing Date Shares Outstanding | 41.09 | 41.08 | 40.93 | 40.6 | 4.37 | 2.53 | Upgrade
|
| Total Common Shares Outstanding | 41.09 | 41.08 | 40.93 | 40.6 | 4.39 | 2.53 | Upgrade
|
| Working Capital | 103.52 | 128.64 | 178.59 | 265.64 | 171.17 | 99.2 | Upgrade
|
| Book Value Per Share | 2.81 | 3.47 | 4.81 | 7.13 | 43.11 | 39.96 | Upgrade
|
| Tangible Book Value | 115.48 | 142.37 | 197.04 | 289.53 | 189.24 | 101.27 | Upgrade
|
| Tangible Book Value Per Share | 2.81 | 3.47 | 4.81 | 7.13 | 43.11 | 39.96 | Upgrade
|
| Machinery | 12.56 | 12.64 | 11.32 | 9.82 | 6.52 | 1.72 | Upgrade
|
| Construction In Progress | - | - | - | 5.35 | 1.28 | 0.29 | Upgrade
|
| Leasehold Improvements | 9.54 | 9.45 | 8.93 | 7.02 | 6.96 | 0.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.